PET & CT Scanner Market Size, Share, Growth, and Industry Analysis, By Type (Digital PET/CT, Analog PET/CT), By Application (Hospitals, Ambulatory Surgical Centres, Research Institutes), Regional Insights and Forecast to 2035
PET & CT Scanner Market Overview
PET & CT Scanner Market size in 2026 is estimated to be USD 8151.22 million, with projections to grow to USD 10181.62 million by 2035 at a CAGR of 2.51%.
The PET & CT Scanner Market is witnessing substantial expansion due to the increasing prevalence of oncology, cardiology, and neurological disorders across global healthcare systems. PET & CT Scanner Market Analysis indicates that more than 45% of diagnostic imaging centers are integrating hybrid imaging systems to improve disease detection accuracy and workflow efficiency. PET & CT Scanner Market Trends reveal that digital imaging technologies now account for nearly 52% of newly installed systems in advanced hospitals. Over 68% of cancer diagnostics in tertiary care facilities involve PET and CT imaging procedures for precise tumor localization and treatment monitoring. PET & CT Scanner Industry Report findings show that more than 58% of healthcare providers prioritize low-dose radiation systems and AI-enabled imaging software. PET & CT Scanner Market Research Report data further highlights that integrated PET/CT systems improve lesion detection rates by approximately 33% compared with standalone modalities, making them critical components of modern diagnostic infrastructure and personalized medicine programs.
The USA PET & CT Scanner Market demonstrates strong technological adoption supported by advanced hospital infrastructure and rising diagnostic imaging procedures. More than 39 million CT examinations are conducted annually in the United States, while PET imaging utilization in oncology exceeds 82% across major cancer centers. Around 61% of newly procured imaging systems in U.S. hospitals are AI-assisted scanners designed for faster reconstruction and reduced scan times. Approximately 48% of healthcare facilities are replacing analog systems with digital PET/CT platforms to improve image clarity and operational efficiency. PET & CT Scanner Market Insights indicate that over 71% of imaging centers in the USA emphasize low-radiation scanning technologies, while mobile PET/CT units have expanded by nearly 26% in rural healthcare networks to increase patient accessibility and diagnostic coverage.
Download FREE Sample to learn more about this report.
Key Findings
- Key Market Driver: More than 67% increase in oncology imaging procedures and 54% higher adoption of hybrid diagnostic systems across tertiary healthcare institutions are accelerating PET & CT Scanner Market Growth.
- Major Market Restraint: Nearly 43% of smaller healthcare facilities report high equipment installation costs, while 38% cite maintenance expenditures and infrastructure limitations as barriers to adoption.
- Emerging Trends: Around 58% of imaging centers are implementing AI-enabled image reconstruction technologies, and 46% are adopting digital PET/CT systems with enhanced detector sensitivity.
- Regional Leadership: North America accounts for approximately 41% of advanced diagnostic imaging installations, while Asia-Pacific records over 36% growth in hospital-based PET/CT deployments.
- Competitive Landscape: More than 49% of manufacturers are focusing on AI-integrated scanners, while 44% are investing in compact hybrid imaging systems for outpatient diagnostic facilities.
- Market Segmentation: Digital PET/CT systems contribute nearly 52% of new installations, whereas oncology applications represent over 63% of total PET & CT scanning utilization globally.
- Recent Development: Approximately 47% of imaging technology providers introduced AI-assisted reconstruction upgrades, while 34% launched low-dose radiation PET/CT imaging platforms for clinical applications.
PET & CT Scanner Market Latest Trends
The PET & CT Scanner Market is evolving rapidly with the integration of advanced digital imaging, artificial intelligence, and low-dose scanning technologies. PET & CT Scanner Market Trends show that nearly 58% of healthcare institutions are investing in AI-based image reconstruction software to improve diagnostic precision and reduce scanning time. Digital detector technology adoption has increased by approximately 49% in newly installed systems because of superior spatial resolution and enhanced lesion detection. PET & CT Scanner Industry Analysis further indicates that over 44% of hospitals now prioritize hybrid imaging systems capable of supporting oncology, cardiology, and neurology diagnostics within a single platform. Mobile PET/CT units are gaining popularity, with installations increasing by nearly 27% in remote healthcare regions to improve accessibility. Around 51% of diagnostic imaging providers are focusing on reducing radiation exposure through advanced dose optimization protocols. In addition, approximately 39% of manufacturers are introducing cloud-connected imaging software for faster data sharing and remote diagnostics. PET & CT Scanner Market Forecast studies also highlight growing demand for personalized imaging workflows and automated quantitative analysis tools in precision medicine applications.
PET & CT Scanner Market Dynamics
DRIVER
"Rising demand for oncology and precision diagnostics"
The increasing burden of cancer and chronic diseases remains the primary growth driver for the PET & CT Scanner Market. More than 64% of oncology specialists rely on PET/CT imaging for accurate tumor staging, recurrence monitoring, and treatment planning. PET & CT Scanner Market Research Report findings reveal that nearly 59% of hospitals have expanded advanced imaging departments to support growing patient volumes in cancer diagnostics. Approximately 71% of tertiary care institutions now integrate PET/CT imaging into multidisciplinary treatment pathways for breast, lung, colorectal, and prostate cancers. In cardiology applications, hybrid imaging utilization has increased by almost 36% for evaluating myocardial viability and coronary artery diseases. Neurological imaging demand has also risen by over 28% due to the growing prevalence of Alzheimer’s disease and epilepsy. PET & CT Scanner Industry Report analysis shows that digital systems improve lesion detectability by approximately 32% compared with traditional scanners. Healthcare providers are increasingly investing in AI-enabled systems capable of reducing image reconstruction time by nearly 41%, improving workflow efficiency and patient throughput. Growing awareness of early disease detection among patients and clinicians is further accelerating PET & CT Scanner Market Opportunities globally.
RESTRAINTS
"High installation and operational expenditure"
Despite strong adoption trends, the PET & CT Scanner Market faces significant restraints associated with infrastructure requirements and equipment maintenance. Nearly 46% of medium-sized healthcare facilities report difficulties in procuring advanced hybrid imaging systems due to high setup and calibration costs. PET & CT Scanner Market Analysis indicates that approximately 39% of imaging centers struggle with operational expenses related to detector replacement, cooling systems, and software upgrades. Radiation shielding and specialized room construction contribute to infrastructure costs for nearly 34% of hospitals planning new installations. In developing healthcare economies, around 42% of facilities continue using refurbished imaging systems because of affordability concerns. Skilled workforce shortages also impact adoption, as nearly 31% of diagnostic centers report limited availability of certified radiologists and nuclear medicine specialists. PET & CT Scanner Market Insights reveal that compliance with radiation safety regulations increases operational complexity for almost 37% of imaging providers. Furthermore, periodic maintenance downtime affects patient scheduling efficiency in approximately 29% of healthcare institutions. These cost-related challenges continue to slow adoption rates among smaller clinics and regional diagnostic centers despite increasing demand for advanced imaging procedures.
OPPORTUNITY
"Expansion of AI-integrated and digital imaging technologies"
The integration of artificial intelligence and digital imaging systems presents substantial opportunities for the PET & CT Scanner Market. Approximately 57% of healthcare providers are adopting AI-assisted imaging solutions to enhance workflow optimization and diagnostic accuracy. PET & CT Scanner Market Trends indicate that automated image segmentation technologies reduce interpretation time by nearly 38%, enabling radiologists to manage higher patient volumes. Digital PET/CT scanners now account for around 52% of newly installed systems due to their superior detector sensitivity and lower radiation exposure. More than 43% of imaging manufacturers are investing in machine learning algorithms capable of identifying abnormalities with improved precision. Cloud-based imaging platforms are also creating opportunities, with adoption increasing by nearly 35% among multi-specialty hospitals for faster data sharing and tele-radiology services. PET & CT Scanner Industry Analysis further highlights rising demand for compact and mobile imaging units in outpatient facilities and rural healthcare centers. Personalized medicine initiatives are expanding the role of PET/CT imaging in therapy response evaluation, with approximately 48% of oncology centers utilizing molecular imaging biomarkers. These technological advancements are expected to enhance accessibility, improve patient outcomes, and create long-term growth opportunities across global healthcare markets.
CHALLENGE
"Radiation exposure concerns and regulatory compliance"
Radiation safety concerns remain a major challenge in the PET & CT Scanner Market. Approximately 41% of patients express concerns regarding repeated exposure to ionizing radiation during diagnostic procedures. PET & CT Scanner Market Outlook studies reveal that nearly 36% of healthcare institutions are implementing stricter radiation dose optimization protocols to address safety concerns. Regulatory compliance requirements related to nuclear medicine operations affect around 33% of imaging facilities globally. Licensing procedures for radioactive tracers and isotope handling continue to create operational complexities for diagnostic centers. Approximately 28% of hospitals report delays in scanner deployment due to lengthy approval processes and infrastructure certification requirements. PET & CT Scanner Market Forecast analysis also indicates that patient demand for low-dose imaging technologies has increased by nearly 47% over recent years. Manufacturers are therefore under pressure to develop advanced scanners capable of minimizing radiation exposure while maintaining high image quality. Ensuring consistent isotope supply chains and maintaining safety standards in radiopharmaceutical handling further complicate operational management for healthcare providers.
PET & CT Scanner Market Segmentation
The PET & CT Scanner Market is segmented by type and application based on imaging technology utilization and clinical diagnostic requirements. PET & CT Scanner Market Segmentation indicates that digital imaging systems account for more than half of newly deployed scanners due to superior image clarity and reduced acquisition time. By application, oncology diagnostics contribute the highest imaging utilization rates, followed by cardiology and neurology examinations. Approximately 63% of PET/CT procedures are associated with cancer detection and therapy monitoring. Increasing demand for precision diagnostics, AI-integrated imaging workflows, and low-dose scanning technologies is driving growth across both segmentation categories within the global PET & CT Scanner Industry.
Download FREE Sample to learn more about this report.
BY TYPE
Digital PET/CT: Digital PET/CT systems are becoming the dominant technology segment in the PET & CT Scanner Market due to improved detector efficiency, enhanced spatial resolution, and reduced scan durations. Nearly 52% of newly installed scanners utilize digital detector technology because of superior image quality and increased sensitivity for detecting small lesions. PET & CT Scanner Market Research Report analysis indicates that digital systems improve diagnostic confidence by approximately 34% in oncology imaging compared with conventional analog platforms. Around 48% of healthcare institutions adopting digital scanners report reductions in imaging workflow time and increased patient throughput. Advanced digital reconstruction software integrated with AI algorithms has improved lesion quantification accuracy by nearly 29%. Approximately 44% of radiology departments prioritize digital systems because they support lower radiation doses while maintaining diagnostic precision. In neurological imaging applications, digital PET/CT platforms improve signal detection by over 31%, making them highly effective for neurodegenerative disease assessment. Cardiology imaging utilization of digital systems has increased by approximately 26% due to improved temporal resolution and faster scan acquisition. PET & CT Scanner Industry Trends further show that compact digital scanners are expanding in outpatient diagnostic centers because of space efficiency and simplified installation requirements. Manufacturers are also integrating cloud-based imaging software into digital systems, enabling real-time image sharing and remote diagnostics across healthcare networks.
Analog PET/CT: Analog PET/CT systems continue to maintain a significant presence in the PET & CT Scanner Market, particularly across cost-sensitive healthcare environments and refurbished equipment segments. Approximately 43% of imaging centers in emerging healthcare economies still operate analog systems due to lower procurement and maintenance costs. PET & CT Scanner Market Analysis indicates that analog scanners remain widely utilized for routine oncology and cardiology imaging procedures where budget constraints limit digital technology adoption. Around 37% of smaller hospitals prefer analog platforms because existing infrastructure is compatible with traditional imaging configurations. Despite technological limitations, analog PET/CT systems continue to provide reliable diagnostic performance for high-volume imaging applications. Approximately 32% of healthcare providers using analog systems have upgraded reconstruction software to improve image processing efficiency and optimize diagnostic workflows. Analog scanners are particularly common in regional diagnostic centers where imaging procedure demand remains stable and operational costs are closely monitored. PET & CT Scanner Market Insights further reveal that nearly 28% of refurbished imaging equipment sales involve analog PET/CT platforms due to affordability advantages. Many manufacturers continue supporting analog product lines with detector enhancements and workflow automation features to extend operational life cycles. Growing replacement demand from aging analog installations is also influencing procurement strategies across healthcare institutions globally.
BY APPLICATION
Hospitals: Hospitals represent the largest application segment in the PET & CT Scanner Market due to the high volume of advanced diagnostic imaging procedures conducted in multi-specialty healthcare institutions. Approximately 68% of PET/CT imaging procedures globally are performed within hospital settings because of the availability of integrated oncology, cardiology, and neurology departments. PET & CT Scanner Market Analysis indicates that nearly 59% of tertiary hospitals are expanding imaging capacities to manage increasing patient demand for cancer screening and treatment planning. Around 54% of hospitals now operate AI-assisted PET/CT systems that improve image reconstruction efficiency and reduce scanning times. Hybrid imaging adoption in emergency and trauma care has increased by approximately 33% in large hospital networks. More than 47% of hospitals are prioritizing low-dose PET/CT technologies to minimize radiation exposure for pediatric and chronic disease patients. In oncology departments, approximately 72% of treatment monitoring protocols involve PET/CT imaging for accurate lesion assessment and therapy response evaluation. Hospitals also account for nearly 61% of integrated radiopharmaceutical usage in nuclear medicine applications. Increasing investments in digital healthcare infrastructure, cloud-based image management, and automated diagnostic workflows continue to strengthen hospital demand within the PET & CT Scanner Industry Report.
Ambulatory Surgical Centres: Ambulatory Surgical Centres are emerging as significant contributors to the PET & CT Scanner Market due to rising demand for cost-effective outpatient imaging services and minimally invasive diagnostic procedures. Approximately 41% of outpatient imaging providers are integrating compact PET/CT systems to improve patient convenience and reduce hospital dependency. PET & CT Scanner Market Trends reveal that ambulatory centers conducting oncology diagnostics have increased by nearly 29% due to faster imaging workflows and shorter patient waiting times. Around 38% of ambulatory surgical facilities now utilize digital PET/CT systems capable of delivering enhanced imaging accuracy in limited-space clinical environments. Cardiovascular imaging procedures within ambulatory centers have expanded by approximately 24% because of growing preventive healthcare initiatives. More than 35% of outpatient diagnostic facilities prioritize AI-enabled scanners that reduce operational complexity and improve image interpretation speed. Patient preference for same-day imaging and rapid reporting services has increased by nearly 44%, supporting demand for advanced outpatient imaging solutions. PET & CT Scanner Market Outlook findings indicate that nearly 31% of mobile PET/CT imaging units are deployed in ambulatory settings to improve accessibility in suburban healthcare networks. The shift toward decentralized healthcare delivery and lower procedural costs continues to create opportunities for PET/CT deployment across ambulatory surgical centers.
Research Institutes: Research institutes play a critical role in advancing the PET & CT Scanner Market through innovation in molecular imaging, radiopharmaceutical development, and precision medicine research. Approximately 46% of clinical imaging research projects involve PET/CT technologies for evaluating disease biomarkers and therapeutic responses. PET & CT Scanner Market Research Report findings show that nearly 39% of academic medical research centers are investing in high-resolution digital imaging systems for neuroscience and oncology studies. Around 34% of research-based imaging procedures focus on neurological disorders such as Alzheimer’s disease, epilepsy, and Parkinson’s disease. Oncology-focused research institutions utilize PET/CT imaging in approximately 58% of experimental treatment assessment programs. More than 29% of imaging research laboratories are integrating AI-assisted image analytics to improve lesion segmentation and quantitative analysis accuracy. PET & CT Scanner Industry Analysis indicates that hybrid imaging technologies improve research efficiency by nearly 32% in longitudinal disease monitoring studies. Research institutes are also expanding radiotracer development programs, with approximately 27% focusing on next-generation molecular imaging compounds for targeted diagnostics. Collaborative partnerships between universities, imaging manufacturers, and healthcare institutions continue driving innovation and technological advancement across the global PET & CT Scanner Market.
PET & CT Scanner Market Regional Outlook
Download FREE Sample to learn more about this report.
North America
North America dominates the PET & CT Scanner Market due to advanced healthcare infrastructure, high imaging procedure volumes, and widespread adoption of digital diagnostic technologies. Approximately 41% of global hybrid imaging installations are concentrated in North America, supported by extensive oncology screening programs and precision medicine initiatives. PET & CT Scanner Market Insights indicate that nearly 63% of hospitals in the region utilize AI-enabled imaging systems to improve diagnostic accuracy and workflow efficiency. Around 57% of healthcare providers prioritize low-dose PET/CT technologies for chronic disease management and pediatric imaging. Oncology applications account for nearly 69% of PET/CT utilization across North American healthcare systems. The region also records approximately 36% higher adoption of cloud-based imaging platforms compared with other regions. Mobile PET/CT unit deployment has increased by nearly 22% in rural healthcare networks to improve patient accessibility. Research and development activities remain strong, with approximately 48% of imaging innovation projects involving AI-assisted image reconstruction and advanced detector technologies. Increasing investments in outpatient diagnostic centers and personalized medicine continue to support PET & CT Scanner Market Growth throughout North America.
Europe
Europe remains a significant region in the PET & CT Scanner Market due to expanding healthcare modernization programs and increasing adoption of advanced imaging systems across public and private hospitals. Approximately 37% of European imaging centers have transitioned to digital PET/CT platforms to improve image sensitivity and reduce scanning times. PET & CT Scanner Market Analysis shows that oncology diagnostics contribute nearly 64% of imaging procedures across European healthcare institutions. Around 42% of hospitals in the region are implementing AI-assisted reconstruction software for enhanced clinical efficiency. Government-supported cancer screening initiatives have increased PET/CT imaging demand by approximately 31% across several European countries. Neurological imaging utilization has also expanded by nearly 24% due to rising prevalence of neurodegenerative disorders. Approximately 33% of diagnostic facilities in Europe focus on low-radiation imaging protocols to comply with patient safety regulations. Hybrid imaging research programs account for nearly 28% of molecular imaging innovation projects in the region. PET & CT Scanner Market Trends further indicate that outpatient imaging centers are expanding rapidly, with approximately 26% growth in compact PET/CT installations designed for decentralized healthcare delivery.
Asia-Pacific
Asia-Pacific is emerging as the fastest expanding region in the PET & CT Scanner Market due to increasing healthcare investments, rising cancer prevalence, and improving diagnostic infrastructure. Approximately 36% growth in hospital-based PET/CT installations has been observed across major healthcare economies in the region. PET & CT Scanner Market Forecast findings indicate that nearly 53% of newly established diagnostic centers in Asia-Pacific are integrating digital imaging systems for oncology and cardiology applications. Around 47% of healthcare institutions are upgrading analog scanners to digital platforms for improved image clarity and workflow optimization. Government healthcare modernization initiatives have increased advanced imaging adoption by approximately 34% in urban medical centers. Oncology imaging procedures account for nearly 61% of PET/CT utilization across the region due to rising awareness of early cancer detection. Mobile PET/CT deployment has increased by around 29% in rural healthcare networks to improve patient accessibility. Approximately 38% of manufacturers are focusing on affordable compact imaging systems tailored for Asia-Pacific healthcare facilities. Research collaborations in molecular imaging and AI-assisted diagnostics continue to expand, supporting long-term PET & CT Scanner Industry Growth across emerging economies.
Middle East & Africa
The Middle East & Africa PET & CT Scanner Market is witnessing steady expansion driven by healthcare infrastructure development, increasing chronic disease prevalence, and rising investment in advanced diagnostic technologies. Approximately 28% of tertiary hospitals in the region have introduced hybrid PET/CT imaging systems to improve oncology diagnostics and treatment planning. PET & CT Scanner Market Research Report analysis indicates that nearly 32% of healthcare modernization initiatives in the Middle East focus on advanced imaging and digital radiology services. Around 26% of imaging centers are implementing AI-assisted software to improve diagnostic efficiency and reduce interpretation time. Oncology imaging utilization has increased by approximately 37% due to rising cancer awareness and screening programs. In Africa, mobile imaging units have expanded by nearly 21% to improve accessibility in underserved healthcare regions. Approximately 24% of healthcare providers prioritize compact PET/CT systems due to infrastructure limitations and operational efficiency requirements. Neurological and cardiovascular imaging procedures are also increasing steadily across urban healthcare facilities. PET & CT Scanner Market Opportunities remain strong as governments and private healthcare organizations continue investing in specialized cancer care centers and modern diagnostic infrastructure.
List of Key PET & CT Scanner Market Companies
- GE Healthcare
- Siemens Healthcare
- Carestream
- ECHO-SON S.A.
- Esaote S.P.A.
- Fonar Corp
- Fujifilm Corp
- Hitachi Medical Corp
- Hologic Inc
- Mindray Medical International LTD
- Neusoft Medical Systems
- Paramed Medical Systems
- Philips Healthcare
- Positron Corp
- Shenzhen Anke High-Tech
Top Companies with Highest Market Share
- GE Healthcare: Approximately 24% of advanced hybrid imaging installations globally are associated with GE Healthcare systems, while nearly 57% of its deployed PET/CT platforms feature AI-assisted image reconstruction and low-dose imaging technologies for oncology diagnostics.
- Siemens Healthcare: Siemens Healthcare accounts for nearly 21% of digital PET/CT deployments worldwide, with approximately 49% of leading oncology centers utilizing its hybrid imaging systems due to enhanced detector sensitivity and automated workflow integration capabilities.
Investment Analysis and Opportunities
The PET & CT Scanner Market continues attracting strong investment activity due to increasing demand for precision diagnostics, AI-assisted imaging, and digital healthcare infrastructure. Approximately 53% of healthcare investors are prioritizing advanced imaging technologies focused on oncology and neurological diagnostics. PET & CT Scanner Market Opportunities are expanding as nearly 47% of hospitals modernize radiology departments with digital and hybrid imaging systems. Around 39% of investment projects are directed toward AI-integrated image reconstruction software and cloud-based imaging platforms. Private healthcare operators are increasing investments in outpatient imaging facilities, with nearly 34% growth in compact PET/CT deployments. Mobile imaging technologies are also receiving attention, as approximately 27% of rural healthcare expansion programs include mobile PET/CT units. Research institutions account for nearly 31% of investments related to radiopharmaceutical innovation and molecular imaging studies. Partnerships between imaging manufacturers and healthcare providers have increased by approximately 29%, supporting advanced detector technology development and workflow automation. Increasing demand for low-radiation imaging systems and personalized medicine diagnostics continues creating long-term investment opportunities across developed and emerging healthcare markets.
New Products Development
The PET & CT Scanner Market is experiencing continuous innovation through the development of digital imaging systems, AI-powered diagnostic software, and compact hybrid imaging platforms. Approximately 49% of manufacturers are introducing next-generation digital PET/CT scanners with enhanced detector sensitivity and faster reconstruction capabilities. PET & CT Scanner Market Trends reveal that nearly 44% of newly launched systems support automated lesion detection and quantitative imaging analysis through artificial intelligence integration. Around 36% of product development initiatives focus on reducing radiation exposure while maintaining high-resolution image quality. Compact imaging systems designed for outpatient diagnostic centers now account for nearly 28% of newly introduced PET/CT products. Manufacturers are also emphasizing cloud-enabled connectivity, with approximately 33% of new systems supporting remote diagnostics and centralized image management. More than 41% of research-driven product launches target oncology imaging applications involving molecular biomarker analysis and therapy response monitoring. Advanced time-of-flight imaging technologies are improving lesion detectability by nearly 29%, further enhancing clinical adoption. Product innovation continues shaping PET & CT Scanner Market Growth through workflow efficiency improvements and expanded diagnostic capabilities.
Five Recent Developments(2023-2025)
- AI-Integrated Imaging Platforms: In 2024, approximately 46% of major imaging manufacturers introduced AI-assisted PET/CT systems capable of reducing image reconstruction times by nearly 38%. These platforms improved workflow efficiency in oncology diagnostics and enhanced automated lesion segmentation accuracy across high-volume radiology departments.
- Low-Dose Imaging Advancements: Around 41% of newly launched PET/CT systems in 2024 focused on radiation dose optimization technologies. Enhanced detector sensitivity and AI-assisted correction algorithms reduced patient radiation exposure by nearly 27% while maintaining diagnostic image quality in oncology and pediatric applications.
- Expansion of Digital PET/CT Systems: Nearly 52% of advanced imaging installations completed during 2024 involved fully digital PET/CT scanners. These systems improved lesion detection rates by approximately 31% and enhanced image clarity in neurological and cardiovascular imaging procedures across specialized healthcare centers.
- Cloud-Based Imaging Integration: Approximately 35% of healthcare providers adopted cloud-enabled PET/CT platforms between 2023 and 2025 to support remote diagnostics and centralized image management. Integration with tele-radiology systems improved collaborative diagnosis efficiency by nearly 24% across healthcare networks.
- Mobile PET/CT Deployment Growth: Mobile PET/CT unit installations increased by approximately 26% during 2024 due to rising demand for accessible imaging services in rural and underserved healthcare regions. Compact hybrid systems improved patient access to oncology diagnostics and reduced imaging wait times by nearly 19%.
Report Coverage Of PET & CT Scanner Market
The PET & CT Scanner Market Report provides comprehensive analysis of imaging technologies, market trends, segme
| REPORT COVERAGE | DETAILS |
|---|---|
|
Market Size Value In |
USD 8151.22 Million in 2026 |
|
Market Size Value By |
USD 10181.62 Million by 2035 |
|
Growth Rate |
CAGR of 2.51% from 2026 - 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
Frequently Asked Questions
The global PET & CT Scanner Market is expected to reach USD 10181.62 Million by 2035.
The PET & CT Scanner Market is expected to exhibit a CAGR of 2.51% by 2035.
GE Healthcare, Siemens Healthcare, Carestream, ECHO-SON S.A., Esaote S.P.A., Fonar Corp, Fujifilm Corp, Hitachi Medical Corp, Hologic Inc, Mindray Medical International LTD, Neusoft Medical Systems, Paramed Medical Systems, Philips Healthcare, Positron Corp, Shenzhen Anke High-Tech
In 2025, the PET & CT Scanner Market value stood at USD 7952.24 Million.
What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology






